Author:
Giles Sarah K.,Stroeher Uwe H.,Eijkelkamp Bart A.,Brown Melissa H.
Publisher
Springer Science and Business Media LLC
Subject
Microbiology (medical),Microbiology
Reference68 articles.
1. Bergogne-Bérézin E. Treatment of Acinetobacter infections. Expert Opin Investig Drugs. 1997;6(2):119–27.
2. McQueary CN, Actis LA. Acinetobacter baumannii biofilms: Variations among strains and correlations with other cell properties. J Microbiol. 2011;49(2):243–50.
3. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5(12):939–51.
4. Shin JA, Chang YS, Kim HJ, Kim SK, Chang J, Ahn CM, et al. Clinical outcomes of tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii infection. Yonsei Med J. 2012;53(5):974–84.
5. Roca I, Espinal P, Vila-Farrés X, Vila J. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front Microbiol. 2012;23(3):148.
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献